Supplementary Table S3 from the Tumor-Suppressive Function of UNC5D and Its Repressed Expression in Renal Cell Carcinoma

Dan Lu,Dong,Yu Zhou,Min Lu,Xue-Wen Pang,Yan Li,Xiao-Jun Tian,Yu Zhang,Jun Zhang

DOI: https://doi.org/10.1158/1078-0432.22450676.v1

2023-01-01

Abstract:Supplementary Table S3 - PDF file 62K, Supplementary Table S3. Correlation of UNC5D expression with methylation and LOH status in primary tumors

What problem does this paper attempt to address?

Supplementary Table S2 from the Tumor-Suppressive Function of unc5d and Its Repressed Expression in Renal Cell Carcinoma

Dan Lu,Dong,Yu Zhou,Min Lü,Xuewen Pang,Yan Li,Xiaojun Tian,Yu Zhang,Jun Zhang

DOI: https://doi.org/10.1158/1078-0432.22450679.v1

2023-01-01

Abstract:Supplementary Table S2 - PDF - file 136K, Supplementary Table S2. Relationship of UNC5D methylation, LOH and clinicopathologic characteristics in patients with RCC
Supplementary Table S1 from the Tumor-Suppressive Function of UNC5D and Its Repressed Expression in Renal Cell Carcinoma

Dan Lu,Dong,Yu Zhou,Min Lu,Xue-Wen Pang,Yan Li,Xiao-Jun Tian,Yu Zhang,Jun Zhang

DOI: https://doi.org/10.1158/1078-0432.22450682.v1

2023-01-01

Abstract:Supplementary Table S1 - PDF file 84K, Supplementary Table S1. Primers and oligonucleotides used in this study
Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.

Dan Lv,Wei Zhao,Dong Dong,Xiao-Ping Qian,Yu Zhang,Xiao-Jun Tian,Jun Zhang

DOI: https://doi.org/10.1016/j.ejca.2011.04.021

IF: 10.002

2011-01-01

European Journal of Cancer

Abstract:Inappropriate gene silencing and subsequent promiscuous activity define the transformation of many solid tumours including renal cell carcinoma (RCC). Here, we report that UNC5C, one of the Netrin-1 receptors, was frequently inactivated in RCC cell lines and primary tumours. UNC5C protein was expressed in the proximal convoluted tubules of the human kidney, the presumed origin of clear cell RCC (ccRCC) and papillary RCC (pRCC). Compared to paired adjacent non-malignant tissues, both UNC5C mRNA and protein expression were significantly down-regulated in RCC. Immunohistochemical analysis showed that UNC5C was inactivated in 94.3% of the samples and the loss of UNC5C occurred at the early stage of RCC. Methylation specific PCR showed that UNC5C promoter was methylated in two renal carcinoma cell lines. Pharmacologic demethylation alone or in combination with inhibition of deacetylation dramatically induced UNC5C expression. Furthermore, bisulfite genomic sequencing (BGS) confirmed that dense methylation existed in UNC5C promoter. In paired tumour samples, UNC5C methylation was observed in 12 out of 44 patients (27.3%). Moreover, we analysed the loss of heterozygosity (LOH) of UNC5C in renal cell carcinoma, the LOH was observed in 27 out of 44 patients (61.4%). Finally, restoration of UNC5C expression suppressed the colony formation of renal carcinoma cells. In addition, UNC5C inhibited tumour cell proliferation, migration and enhanced chemosensitivity to cisplatin and etoposide. Therefore, UNC5C acts as a tumour suppressor in RCC and is down-regulated in RCC. Loss of heterozygosity and DNA methylation contribute to the inactivation of UNC5C in renal cell carcinoma.
Genetic and epigenetic control of UNC 5 C expression in human renal cell carcinoma

D. Lv,Wei Zhao,D. Dong,X. Qian,Yu Zhang,Xiao-Jun Tian,Jun Zhang

2011-01-01

Abstract:Inappropriate gene silencing and subsequent promiscuous activity define the transformation of many solid tumours including renal cell carcinoma (RCC). Here, we report that UNC5C, one of the Netrin-1 receptors, was frequently inactivated in RCC cell lines and primary tumours. UNC5C protein was expressed in the proximal convoluted tubules of the human kidney, the presumed origin of clear cell RCC (ccRCC) and papillary RCC (pRCC). Compared to paired adjacent non-malignant tissues, both UNC5C mRNA and protein expression were significantly down-regulated in RCC. Immunohistochemical analysis showed that UNC5C was inactivated in 94.3% of the samples and the loss of UNC5C occurred at the early stage of RCC. Methylation specific PCR showed that UNC5C promoter was methylated in two renal carcinoma cell lines. Pharmacologic demethylation alone or in combination with inhibition of deacetylation dramatically induced UNC5C expression. Furthermore, bisulfite genomic sequencing (BGS) confirmed that dense methylation existed in UNC5C promoter. In paired tumour samples, UNC5C methylation was observed in 12 out of 44 patients (27.3%). Moreover, we analysed the loss of heterozygosity (LOH) of UNC5C in renal cell carcinoma, the LOH was observed in 27 out of 44 patients (61.4%). Finally, restoration of UNC5C expression suppressed the colony formation of renal carcinoma cells. In addition, UNC5C inhibited tumour cell proliferation, migration and enhanced chemosensitivity to cisplatin and etoposide. Therefore, UNC5C acts as a tumour suppressor in RCC and is down-regulated in RCC. Loss of heterozygosity and DNA methylation contribute to the inactivation of UNC5C in renal cell carcinoma. 2011 Elsevier Ltd. All rights reserved.
Table S3, S5-S7, S10-S18, S21 from Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma

Zhenyuan Yu,Yufang Lv,Cheng Su,Wenhao Lu,RuiRui Zhang,Jiaping Li,Bingqian Guo,Haibiao Yan,Deyun Liu,Zhanbin Yang,Hua Mi,Linjian Mo,Yi Guo,Wenyu Feng,Haotian Xu,Wenyi Peng,Jiwen Cheng,Aruo Nan,Zengnan Mo

DOI: https://doi.org/10.1158/0008-5472.22433229.v1

2023-01-01

Abstract:Table S3, S5-S7, S10-S18, S21
A five-gene methylation signature predicts overall survival of patients with clear cell renal cell carcinoma

Xiao Jing,Gang Xu,Yu Gong,Junlong Li,LingfengWu,Wei Zhu,Yi He,Zhongyi Li,Shouhua Pan

DOI: https://doi.org/10.1002/jcla.24031

Abstract:Background: In this study, we aimed to screen methylation signatures associated with the prognosis of patients with clear cell renal cell carcinoma (ccRCC). Methods: Gene expression and methylation profiles of ccRCC patients were downloaded from publicly available databases, and differentially expressed genes (DEGs)-differentially methylated genes (DMGs) were obtained. Subsequently, gene set enrichment and transcription factor (TF) regulatory network analyses were performed. In addition, a prognostic model was constructed and the relationship between disease progression and immunity was analyzed. Results: A total of 23 common DEGs-DMGs were analyzed, among which 14 DEGs-DMGs were obtained with a cutoff value of PCC < 0 and p < 0.05. The enrichment analysis showed that the 14 DEGs-DMGs were enriched in three GO terms and three KEGG pathways. In addition, a total of six TFs were shown to be associated with the 14 DEGs-DMGs, including RP58, SOX9, NF-κB65, ATF6, OCT, and IK2. A prognostic model using five optimized DEGs-DMGs which efficiently predicted survival was constructed and validated using the GSE105288 dataset. Additionally, four types of immune cells (NK cells, macrophages, neutrophils, and cancer-associated fibroblasts), as well as ESTIMATE, immune, and stromal scores were found to be significantly correlated with ccRCC progression (normal, primary, and metastasis) in addition to the five optimized DEGs-DMGs. Conclusion: A five-gene methylation signature with the predictive ability for ccRCC prognosis was investigated in this study, consisting of CCNB2, CDKN1C, CTSH, E2F2, and ERMP1. In addition, potential targets for methylation-mediated immunotherapy were highlighted.
Supplementary Table S5 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma

Dongliang Leng,Ziyi Yang,Heng Sun,Chengcheng Song,Chen Huang,Ka U. Ip,Guokai Chen,Chu-Xia Deng,Xiaohua Douglas Zhang,Qi Zhao

DOI: https://doi.org/10.1158/1078-0432.24229797.v1

2023-01-01

Abstract:Supplementary Table S5. DE genes in C2 (High) compared with C3 (Moderate).
Supplementary Table S9 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Dongliang Leng,Ziyi Yang,Heng Sun,Chengcheng Song,Chen Huang,Ka U. Ip,Guokai Chen,Chu‐Xia Deng,Xiaohua Douglas Zhang,Qi Zhao

DOI: https://doi.org/10.1158/1078-0432.24229782.v1

2023-01-01

Abstract:Supplementary Table S9. DE miRNAs in C2 (High) compared with C1 (Low).
Supplementary Table 4 from DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Jianzhong Cao,Yongmei Song,Nan Bi,Jie Shen,Wenyang Liu,Jing Fan,Guogui Sun,Tong Tong,Jie He,Yuankai Shi,Xun Zhang,Ning Lu,Yinghua He,Hongyu Zhang,Kelong Ma,Xiaoying Luo,Lei Lv,Hui Deng,Jing Cheng,Jingde Zhu,Luhua Wang,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22397195

2023-01-01

Abstract:PDF file - 40K, ECOG Performance Status.
Supplemental Table S1-5 from Dissecting LncRNA Roles in Renal Cell Carcinoma Metastasis and Characterizing Genomic Heterogeneity by Single-Cell RNA-seq

Xue Li,Xianwen Meng,Cong Wei,Yincong Zhou,Hongjun Chen,He Huang,Ming Chen

DOI: https://doi.org/10.1158/1541-7786.22510819.v1

2023-01-01

Abstract:Table S1. Information of RNA-seq samples. Table S2. Metastatic vs Primary differentially expressed lncRNAs and PCGs. Table S3. Correlation between CMAL-clusters and clinicopathological features. Table S4. CMALs significantly associated with TNF signaling pathway. Table S5. The qRT-PCR primer sequences of four CMALs and two PCGs.
Supplementary Tables 1 - 3 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer

Hongyan Yu,Wen Ye,Jiangxue Wu,Xiangqi Meng,Ran-yi Liu,Xiaofang Ying,Yi Zhou,Hui Wang,Changchuan Pan,Wenlin Huang

DOI: https://doi.org/10.1158/1078-0432.22449434

2023-01-01

Abstract:PDF file - 178KB, Supplementary Table 1. Clinicopathological findings and correlation with Sirt7 expression. Supplementary Table 2. Univariate analysis of clinicopathological parameters and molecular expression ( I and II). Supplementary Table 3. Multivariate analysis for I and II patients� OS.
Supplementary Tables 1-3, Supplementary Figures 1-5 from Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial–Mesenchymal Transition

Bo Pang,Nan Wu,Rongwei Guan,Lin Peng,Xinlei Li,Su Li,Liudi Tang,Ying Guo,Jialei Chen,Donglin Sun,Huiling Sun,Jialin Dai,Jing Bai,Guohua Ji,Peng Liu,An Liu,Qiushi Wang,Shifu Xiao,Songbin Fu,Jun Yan

DOI: https://doi.org/10.1158/1078-0432.22468584

2023-01-01

Abstract:Table S1: Primary antibodies used for western blot analysis; Table S2: Univariate and multivariate Cox regression analysis of different prognosis factors in patients with LUAD from TMAS; Table S3: related to Figure 4 and 6. Correlation between expression of RCC2and EMT markers and between expression of RCC2 and p-JNK inLUAD; Supplementary Figure 1. Verifying specificity of anti-RCC2 antibody; Supplementary Figure 2 (related to Figure 1). Kaplan-Meier survival analysis according to RCC2 expression in 204 LUAD patients of GEO dataset(GSE31210) from PrognoScan(log-rank test); Supplementary Figure 3 (related to Figure 4). Representative IHC staining for RCC2, N-cadherin, α-SMA, β-catenin, and E-cadherinin serial sections of patients with LUAD; Supplementary Figure 4 (related to Figure 5). Knockdown of RCC2 suppressed xenograft tumor growth in vivo; Supplementary Figure 5 (related to Figure 6) Representative IHC staining for RCC2 and p-JNK in serial sections of LUAD patients.
Supplementary Table S10 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Dongliang Leng,Ziyi Yang,Heng Sun,Chengcheng Song,Chen Huang,Ka U. Ip,Guokai Chen,Chu‐Xia Deng,Xiaohua Douglas Zhang,Qi Zhao

DOI: https://doi.org/10.1158/1078-0432.24229830

2023-01-01

Abstract:Supplementary Table S10. Survival analysis for DEmiRNA.
Tumor-suppressive function of UNC5D in papillary thyroid cancer

Man-Man Zhang,Feng Sun,Bing Cui,Le-Le Zhang,Ya Fang,Yan Li,Rui-Jia Zhang,Xiao-Ping Ye,Yu-Ru Ma,Bing Han,Huai-Dong Song

DOI: https://doi.org/10.18632/oncotarget.21759

2017-10-10

Oncotarget

Abstract:BACKGROUND: Studies have shown an association of the UNC5D gene with kidney and bladder cancer and neuroblastoma. We investigated whether UNC5D acts as a tumor suppressor in papillary thyroid carcinoma (PTC).METHODS: Primary PTC tumors and matched normal thyroid tissues were obtained from 112 patients to detect UNC5D mRNA by real-time PCR. Genomic DNA sequencing was performed to detect BRAF mutation in PTC tumors. The association between UNC5D expression and clinicopathological data from PTC patients was reviewed retrospectively. PTC-derived cancer cell lines TPC-1 and K1 with stable transfection of UNC5D were used to investigate the functions of UNC5D. Flow cytometry, CCK-8, Transwell assay and scratch tests were used to examine cell cycle distribution, proliferation and migration.RESULTS: The expression of UNC5D was significantly decreased in PTC compared with adjacent normal thyroid tissues. Lower UNC5D expression was significantly associated with aggressive tumor behaviors, such as lymph node metastasis and BRAF mutation. Overexpression of UNC5D significantly suppressed malignant cell behaviors, including cell proliferation and migration, as well as tumor growth in vivo.CONCLUSIONS: These findings suggest a potential tumor suppressor role of UNC5D in PTC progression; and provide insight into potential clinical relevance for the prognosis of PTC.
Supplementary Table S12 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Dongliang Leng,Ziyi Yang,Heng Sun,Chengcheng Song,Chen Huang,Ka U. Ip,Guokai Chen,Chu-Xia Deng,Xiaohua Douglas Zhang,Qi Zhao

DOI: https://doi.org/10.1158/1078-0432.24229824

2023-01-01

Abstract:Supplementary Table S12. MREs between mRNAs and miRNAs in the survival-related ceRNA network.
Supplementary Tables 1 Through 3 from CBX4 Suppresses Metastasis Via Recruitment of HDAC3 to the Runx2 Promoter in Colorectal Carcinoma

Xin Wang,Liping Li,Yuanzhong Wu,Ruhua Zhang,Meifang Zhang,Dan Liao,Gang Wang,Ge Qin,Rui-hua Xu,Tiebang Kang

DOI: https://doi.org/10.1158/0008-5472.22412870.v1

2023-01-01

Abstract:Table S1 is the correlation between CBX4 expression and Runx2 expression of CRC patients, Table S2 is correlation between CBX4 expression and clinicopathologic characteristics of CRC patients, and Table S3 is univariate and multivariate analysis for overall survival.
UNC5A, an epigenetically silenced gene, functions as a tumor suppressor in non-small cell lung cancer

Silu Ding,Hongwei Zhang,Xinyu Zhao,Jun Dang,Guang Li

DOI: https://doi.org/10.1016/j.sjbs.2020.09.023

IF: 4.052

2020-11-01

Saudi Journal of Biological Sciences

Abstract:UNC5A has been reported to be related with human cancers. However, the function and mechanism in non-small cell lung carcinoma (NSCLC) remains unknown. Materials and We analyzed two NSCLC cell lines (A549 and H157), one normal human bronchial epithelial cell line (BEAS-2B) and the tissues of NSCLC. We used quantitative real-time PCR (qRT-PCR), western blot and immunohistochemical (IHC) staining to examine the expression of UNCA5. Methylation status of the UNC5A promoter was analyzed using methylation-specific PCR (MSP) and bisulfite sequencing PCR (BSP). We used western blot to analyzed protein levels of PI3K/Akt pathway. We found that the mRNA expression of UNCA5 was significantly downregulated in NSCLC cells and tissues. The promoter of UNC5A was hypermethylated in NSCLC cells compared to normal control cells. The expression of UNC5A could be reversed by demethylation agent in NSCLC cells. The expression of UNC5A was decreased in NSCLC samples and significantly associated with the advanced types of NSCLC. Functionally, knockdown of UNC5A promoted cell proliferation, migration, invasion and induced apoptosis in NSCLC, overexpression of UNC5A yielded the opposite result. Moreover, we found that UNC5A negatively regulated PI3K/Akt signaling pathway in NSCLC. UNC5A is a novel epigenetically silenced gene in NSCLC and consequent under-expression of UNC5A may contribute to NSCLC tumorigenesis through regulating PI3K/Akt pathway.

biology
Supplementary Table S4 from Transcription Factor SOX18 Promotes Clear Cell Renal Cell Carcinoma Progression and Alleviates Cabozantinib-Mediated Inhibitory Effects

Yin Huaqi,Qin Caipeng,Wang Qiang,Du Yiqing,Dai Xiang,Tang Xu,Zhang Xiaowei,Li Qing,Liu Shijun,Xu Tao

DOI: https://doi.org/10.1158/1535-7163.22509586.v1

2023-01-01

Abstract:Univariable and multivariable analysis for ccRCC patients' overall survival using Cox's proportional hazards model
Supplementary Table S2 from Transcription Factor SOX18 Promotes Clear Cell Renal Cell Carcinoma Progression and Alleviates Cabozantinib-Mediated Inhibitory Effects

Han Yin,Chunxia Qin,Qiang Wang,Yun Du,Xuanming Ding,Tao Xu,Xiaowei Zhang,Qing Li,Shijun Liu

DOI: https://doi.org/10.1158/1535-7163.22509592

2023-01-01

Abstract:Information of antibodies used in the present study
A Systematic Analysis of the Role of Unc-5 Netrin Receptor A (UNC5A) in Human Cancers.

Zonglang Zhou,Bingfu Fan,Hongrong Cheng,Ming Wang,Jun Xie,Mingyuan Zou,Yi Yang

DOI: https://doi.org/10.3390/biom12121826

IF: 6.064

2022-01-01

Biomolecules

Abstract:Unc-5 netrin receptor A (UNC5A), a netrin family receptor, plays a key role in neuronal development and subsequent differentiation. Recently, studies have found that UNC5A plays an important role in multiple cancers, such as bladder cancer, non-small cell lung carcinoma, and colon cancer but its pan-cancer function is largely unknown. Herein, the R software and multiple databases or online websites (The Cancer Genome Atlas (TCGA), The Genotype-Tissue Expression (GTEx), The Tumor Immune Estimation Resource (TIMER), The Gene Set Cancer Analysis (GSCA), Gene Expression Profiling Interactive Analysis (GEPIA), and cBioPortal etc.) were utilized to examine the role of UNC5A in pan-cancer. UNC5A was found to be highly expressed across multiple human cancer tissues and cells, was linked to clinical outcomes of patients, and was a potential pan-cancer biomarker. The mutational landscape of UNC5A exhibited that patients with UNC5A mutations had poorer progress free survival (PFS) in head and neck squamous cell carcinoma (HNSC) and prostate adenocarcinoma (PRAD). Furthermore, UNC5A expression was associated with tumor mutation burden (TMB), neoantigen, tumor microenvironment (TME), tumor microsatellite instability (MSI), immunomodulators, immune infiltration, DNA methylation, immune checkpoint (ICP) genes, and drug responses. Our results suggest the potential of UNC5A as a pan-cancer biomarker and an efficient immunotherapy target, which may also guide drug selection for some specific cancer types in clinical practice.

Supplementary Table S3 from the Tumor-Suppressive Function of UNC5D and Its Repressed Expression in Renal Cell Carcinoma

Supplementary Table S2 from the Tumor-Suppressive Function of &lt;i&gt;unc5d&lt;/i&gt; and Its Repressed Expression in Renal Cell Carcinoma

Supplementary Table S1 from the Tumor-Suppressive Function of UNC5D and Its Repressed Expression in Renal Cell Carcinoma

Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.

Genetic and epigenetic control of UNC 5 C expression in human renal cell carcinoma

Table S3, S5-S7, S10-S18, S21 from Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma

A five-gene methylation signature predicts overall survival of patients with clear cell renal cell carcinoma

Supplementary Table S5 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma

Supplementary Table S9 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Supplementary Table 4 from DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Supplemental Table S1-5 from Dissecting LncRNA Roles in Renal Cell Carcinoma Metastasis and Characterizing Genomic Heterogeneity by Single-Cell RNA-seq

Supplementary Tables 1 - 3 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer

Supplementary Tables 1-3, Supplementary Figures 1-5 from Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial–Mesenchymal Transition

Supplementary Table S10 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Tumor-suppressive function of UNC5D in papillary thyroid cancer

Supplementary Table S12 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Supplementary Tables 1 Through 3 from CBX4 Suppresses Metastasis Via Recruitment of HDAC3 to the Runx2 Promoter in Colorectal Carcinoma

UNC5A, an epigenetically silenced gene, functions as a tumor suppressor in non-small cell lung cancer

Supplementary Table S4 from Transcription Factor SOX18 Promotes Clear Cell Renal Cell Carcinoma Progression and Alleviates Cabozantinib-Mediated Inhibitory Effects

Supplementary Table S2 from Transcription Factor SOX18 Promotes Clear Cell Renal Cell Carcinoma Progression and Alleviates Cabozantinib-Mediated Inhibitory Effects

A Systematic Analysis of the Role of Unc-5 Netrin Receptor A (UNC5A) in Human Cancers.

Supplementary Table S2 from the Tumor-Suppressive Function of <i>unc5d</i> and Its Repressed Expression in Renal Cell Carcinoma